286 related articles for article (PubMed ID: 16579858)
1. Evaluation of the kinase domain of c-KIT in canine cutaneous mast cell tumors.
Webster JD; Kiupel M; Yuzbasiyan-Gurkan V
BMC Cancer; 2006 Apr; 6():85. PubMed ID: 16579858
[TBL] [Abstract][Full Text] [Related]
2. The role of c-KIT in tumorigenesis: evaluation in canine cutaneous mast cell tumors.
Webster JD; Yuzbasiyan-Gurkan V; Kaneene JB; Miller R; Resau JH; Kiupel M
Neoplasia; 2006 Feb; 8(2):104-11. PubMed ID: 16611403
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and importance of internal tandem duplications in exons 11 and 12 of c-kit in mast cell tumors of dogs.
Downing S; Chien MB; Kass PH; Moore PE; London CA
Am J Vet Res; 2002 Dec; 63(12):1718-23. PubMed ID: 12492288
[TBL] [Abstract][Full Text] [Related]
4. The use of KIT and tryptase expression patterns as prognostic tools for canine cutaneous mast cell tumors.
Kiupel M; Webster JD; Kaneene JB; Miller R; Yuzbasiyan-Gurkan V
Vet Pathol; 2004 Jul; 41(4):371-7. PubMed ID: 15232137
[TBL] [Abstract][Full Text] [Related]
5. Clustering of activating mutations in c-KIT's juxtamembrane coding region in canine mast cell neoplasms.
Ma Y; Longley BJ; Wang X; Blount JL; Langley K; Caughey GH
J Invest Dermatol; 1999 Feb; 112(2):165-70. PubMed ID: 9989791
[TBL] [Abstract][Full Text] [Related]
6. Cellular proliferation in canine cutaneous mast cell tumors: associations with c-KIT and its role in prognostication.
Webster JD; Yuzbasiyan-Gurkan V; Miller RA; Kaneene JB; Kiupel M
Vet Pathol; 2007 May; 44(3):298-308. PubMed ID: 17491070
[TBL] [Abstract][Full Text] [Related]
7. Proof of target for SU11654: inhibition of KIT phosphorylation in canine mast cell tumors.
Pryer NK; Lee LB; Zadovaskaya R; Yu X; Sukbuntherng J; Cherrington JM; London CA
Clin Cancer Res; 2003 Nov; 9(15):5729-34. PubMed ID: 14654558
[TBL] [Abstract][Full Text] [Related]
8. Tandem duplication of KIT exon 11 influences the proteome of canine mast cell tumours.
Schlieben P; Meyer A; Weise C; Bondzio A; Gruber AD; Klopfleisch R
J Comp Pathol; 2013 May; 148(4):318-22. PubMed ID: 22935087
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of exon 11 internal tandem duplications in the C-KIT proto-oncogene in Australian canine mast cell tumours.
Tamlin VS; Kessell AE; Mccoy RJ; Dobson EC; Smith TS; Hebart M; Brown L; Mitrovic D; Peaston AE
Aust Vet J; 2017 Oct; 95(10):386-391. PubMed ID: 28948627
[TBL] [Abstract][Full Text] [Related]
10. Detection of c-kit mutations in canine mast cell tumors using fluorescent polyacrylamide gel electrophoresis.
Jones CL; Grahn RA; Chien MB; Lyons LA; London CA
J Vet Diagn Invest; 2004 Mar; 16(2):95-100. PubMed ID: 15053358
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and prognostic value of c-kit and TP53 mutations in canine mast cell tumours.
Vozdova M; Kubickova S; Fictum P; Fröhlich J; Jelinek F; Rubes J
Vet J; 2019 May; 247():71-74. PubMed ID: 30971355
[TBL] [Abstract][Full Text] [Related]
12. Spontaneous canine mast cell tumors express tandem duplications in the proto-oncogene c-kit.
London CA; Galli SJ; Yuuki T; Hu ZQ; Helfand SC; Geissler EN
Exp Hematol; 1999 Apr; 27(4):689-97. PubMed ID: 10210327
[TBL] [Abstract][Full Text] [Related]
13. Mutation and methylation status of KIT and TP
Vozdova M; Kubickova S; Fictum P; Cernohorska H; Fröhlich J; Rubes J
Vet Comp Oncol; 2020 Sep; 18(3):438-444. PubMed ID: 31574575
[TBL] [Abstract][Full Text] [Related]
14. Validation of the prognostic value of histopathological grading or c-kit mutation in canine cutaneous mast cell tumours: a retrospective cohort study.
Takeuchi Y; Fujino Y; Watanabe M; Takahashi M; Nakagawa T; Takeuchi A; Bonkobara M; Kobayashi T; Ohno K; Uchida K; Asano K; Nishimura R; Nakayama H; Sugano S; Ohashi Y; Tsujimoto H
Vet J; 2013 Jun; 196(3):492-8. PubMed ID: 23384436
[TBL] [Abstract][Full Text] [Related]
15. Activating mutations in the catalytic or juxtamembrane domain of c-kit in splenic mast cell tumors of cats.
Dank G; Chien MB; London CA
Am J Vet Res; 2002 Aug; 63(8):1129-33. PubMed ID: 12171166
[TBL] [Abstract][Full Text] [Related]
16. Mutations in Exons 8 and 11 of
Chen P; Marconato L; Sabattini S; Kiupel M
Vet Sci; 2022 Sep; 9(9):. PubMed ID: 36136708
[TBL] [Abstract][Full Text] [Related]
17. Receptor Tyrosine Kinase Expression Profiles in Canine Cutaneous and Subcutaneous Mast Cell Tumors.
Thompson JJ; Morrison JA; Pearl DL; Boston SE; Wood GA; Foster RA; Coomber BL
Vet Pathol; 2016 May; 53(3):545-58. PubMed ID: 26459517
[TBL] [Abstract][Full Text] [Related]
18. The secondary KIT mutation p.Ala510Val in a cutaneous mast cell tumour carrying the activating mutation p.Asn508Ile confers resistance to masitinib in dogs.
Gentilini F; Turba ME; Dally C; Takanosu M; Kurita S; Bonkobara M
BMC Vet Res; 2020 Feb; 16(1):64. PubMed ID: 32075643
[TBL] [Abstract][Full Text] [Related]
19. Concordance of c-kit mutational status in matched primary and metastatic cutaneous canine mast cell tumors at baseline.
Marconato L; Zorzan E; Giantin M; Di Palma S; Cancedda S; Dacasto M
J Vet Intern Med; 2014; 28(2):547-53. PubMed ID: 24372836
[TBL] [Abstract][Full Text] [Related]
20. All subunits of the interleukin-2 receptor are expressed by canine cutaneous mast cell tumours.
Meyer A; Gruber AD; Klopfleisch R
J Comp Pathol; 2013 Jul; 149(1):19-29. PubMed ID: 23276382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]